|Rainbow Coral Corp. (RBCC) Targets the Latest Biotechnologies|
Rainbow Coral, through their wholly-owned subsidiary Rainbow Biosciences, seeks partnership with biotechnology developers to deliver profitable new medical technologies and innovations, focusing on commercialization potential in key areas such as Alzheimer’s, Parkinson’s, and cancer.
An example of the company’s activities is their joint venture partnership with Nano3D BioSciences (n3D), a Texas company with a unique technology for the rapid culturing of cells in three dimensions using magnetic levitation. Compared with conventional cell cultures grown on flat surfaces, these 3D cultures form tissues that more closely resemble those found in the human body. The technique has the potential to drastically reduce the cost of developing new drugs as well as eliminate the use of animals when testing the safety of manufactured chemicals. Remarkably, the magnetic levitation technology that Nano3D BioSciences currently offers to grow such things as lifelike human lung tissue could one day lead to lab-grown, implantable human organs.
RBCC CEO, Patrick Brown, commented on the Bio-Assembler technology and on Dr. Souza, one of its co-inventors/creators: “Nano3D’s Bio-Assembler technology was recently used to create the first lab-grown lung tissue with organized layers of cells, and incredibly enough, that’s only the tip of the iceberg. Dr. Souza and n3D are truly on the cutting edge of regenerative medicine, and we couldn’t be more excited to help market it to elite laboratories and researchers around the globe.”
Last year, Rainbow BioSciences, RBCC’s biotech division, signed a joint venture agreement with n3D to help develop and market the Bio-Assembler. The system utilizes a proprietary process that enables scientists to grow cells in a three-dimensional environment using nanoparticles that produce magnetic fields to lift cells from the bottom of petri dishes. Rainbow BioSciences plans to develop new medical and research technology innovations to compete alongside companies such as Bristol Myers Squibb, Abbott Laboratories, and Amgen.
For additional information, visit the company’s website at www.RainbowbioSciences.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net